Click here to go to the previous page
Managing a Complex Outsourcing Collaboration
Program Code:
129
Date:
Monday, June 25, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Andy is currently responsible for the $1.6 billion alliance between Covance Lilly and that includes activities spanning the drug development process. He has over 25 years of broad industry experience including 24 years at Eli Lilly and Company, most recently as Director of Alliance Management.
|
PRESENTER
(S):
Dr. Takacs received her BS degree in Biology from Ithaca College & her PhD in pharmacology from the Univ of Kentucky. Her pharmaceutical research career has spanned 2 decades. She joined Eli LIlly in 2000 where she has held senior director roles in Drug Disposition & External Strategic Partnerships.
|
Andy Lee,
Genzyme Corporation, United States
Andy heads Global Clinical Operations at Genzyme, and is responsible for all global/regional clinical trials. Andy has over 17 years industry experience with interests in Human Subject Protection, Multiregional Studies, Quality and Compliance and finding more efficient ways to run clinical trials.
|
Jacques Mulder, Deloitte Consulting LLP, United States
Andy is currently responsible for the $1.6 billion alliance between Covance Lilly and that includes activities spanning the drug development process. He has over 25 years of broad industry experience including 24 years at Eli Lilly and Company, most recently as Director of Alliance Management.
|
Description
Pharma/CRO relationships have emerged as a critical success factor in the continued growth of the pharma industry. However, managing these relationships continues to be a challenge for many companies. A groundbreaking pharma/CRO partnership has demonstrated that strategic partnerships can deliver value beyond traditional transactional models. Best practices have emerged regarding the management of such a complex relationship, and this session will review key success factors as well as a model for managing large complex partnerships, examining metrics, governance, and transaction versus collaboration.
Learning Objectives:
Discuss novel outsourcing models and the implications for successful implementation
Describe approaches necessary for the transition from transactional to collaboration-based outsourcing.